Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Bondiloxs Topical Hemostatic Granules

K-Number: K161274 · 2017-01-18

Decision Date2017-01-18
Product CodeQSY
DecisionSubstantially Equivalent

Device Summary

Bondiloxs Topical Hemostatic Granules is the device name listed in this FDA 510(k) record. The listed applicant is Medtrade Products , Ltd.. It received FDA 510(k) clearance on 2017-01-18 under 510(k) number K161274. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Bondiloxs Topical Hemostatic Granules?

Bondiloxs Topical Hemostatic Granules is a medical device that received FDA 510(k) clearance on 2017-01-18. The listed applicant is Medtrade Products , Ltd.. The 510(k) number is K161274.

When did Bondiloxs Topical Hemostatic Granules receive FDA 510(k) clearance?

Bondiloxs Topical Hemostatic Granules received FDA 510(k) clearance on 2017-01-18, under 510(k) number K161274.

Who is the listed applicant for Bondiloxs Topical Hemostatic Granules?

The FDA 510(k) record lists Medtrade Products , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Bondiloxs Topical Hemostatic Granules?

The FDA product code for Bondiloxs Topical Hemostatic Granules is QSY.

Other records listing Medtrade Products , Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: QSY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.